Newsletter Subject

COVID Still Deadlier Than the Flu -- But the Gap Is Narrowing

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, May 18, 2024 11:16 AM

Email Preheader Text

Weekly Review Saturday, May 18, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT CME S

[MEDPAGE TODAY]( Weekly Review Saturday, May 18, 2024 [COVID Still Deadlier Than the Flu -- But the Gap Is Narrowing]( [Doctor Fined for Prescribing Ivermectin for COVID]( [Antibiotic for Treating Sepsis Linked to Increased Mortality]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches]( [Lost in the Haze: What Would Rescheduling Marijuana Really Do?]( [NFL Team Doc Pleads Guilty in Double Fatality Crash; Doc Charged in 100 MPH Crash]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Balloon Pump Warning; Afib Rhythm Control vs Dementia; Doc's Sex Crime Charges]( CME SPOTLIGHT [Taking Charge of My Breast Cancer Journey: A Patient Town Hall]( [Low Testosterone Linked With Mortality Risk in Aging Men]( [Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines]( [Teen Died From Eating Spicy Chip as Part of Social Media Challenge, Autopsy Says]( CME SPOTLIGHT [The Future of NSCLC Care: Leveraging Biomarker Testing in the Management of Early-Stage, Resectable Disease]( ['A Fascinating Medical Mystery': What We Heard This Week]( [Taking Telemedicine Visits From Your Kitchen? Think Again]( [Low Risk for New-Onset Thyroid Diseases After mRNA Vaccines]( CME SPOTLIGHT [Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm]( [Farm-to-Hospital Meals Can Help Protect Patients and the Climate]( [MedPod Today: RFK Jr.'s Ailments; Tenpenny Gets License Back; Shady Stem Cell Shots]( [Over 400 Physicians From Delaware's ChristianaCare Move to Unionize]( CME SPOTLIGHT [Novel and Emerging Evidence in Early-Stage Breast Cancer]( [Cancer and Intimate-Care Products; Boost for CRC Stool Tests; Biopsy by Ultrasound?]( [Superbugs Pose a Deadly Threat to Cystic Fibrosis Patients]( [Yet Another Benefit for Metformin?]( CME SPOTLIGHT [Applying the Latest Clinical Evidence to Treatment Plans for Pediatric Patients With Hodgkin Lymphoma]( [U.S. News Introduces List of Best Outpatient Surgery Centers]( [Mail-Order Medication Abortion Effective and Acceptable to Patients]( [How New Doctors Can Crush Their First Contract]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [Cyberattack on Ascension Diverts Ambulances, Takes EHRs Offline]( [Mortality in U.S. Youth; Gene Therapy for Sickle Cell Disease]( [Reflecting on Two Decades in Medicine: Advice to New Graduates]( CME SPOTLIGHT [Latest Clinical Evidence in Adult Diffuse Low-Grade Glioma]( [HHS Suspends Federal Funding for Group Tied to Wuhan Lab]( [Will AI Replace Radiologists, or Just Make Them Better Than Ever?]( [Liver Disease, High Lipoprotein(a) Tied to Higher MI Risk in Diabetes Patients]( [Which Patients With Diabetes and Ketoacidosis Face Higher Death Risk?]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-05-18&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.